STOCK TITAN

[S-8 POS] Penns Woods Bancorp Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

NewGenIvf Group Limited (Nasdaq: NIVF) has declared a 1-for-5 reverse stock split of its Class A Ordinary Shares. The action becomes effective 12:01 a.m. ET on 4 Aug 2025; trading on Nasdaq will begin that morning on a split-adjusted basis under the same ticker but with new CUSIP G0544E303.

The split will cut outstanding shares from 9,142,869 to ≈1,828,574. Every five pre-split shares convert into one post-split share. Fractional entitlements will be rounded up to the nearest whole share—no cash will be paid. All options, warrants and other convertible securities will be proportionally adjusted (share count ÷ 5) in line with plan terms, rounded to whole shares.

No other operational or financial information was provided; the filing strictly covers mechanics and timing of the corporate action.

NewGenIvf Group Limited (Nasdaq: NIVF) ha annunciato uno frazionamento azionario inverso di tipo 1-per-5 delle sue Azioni Ordinarie di Classe A. L'operazione entrerà in vigore alle 12:01 a.m. ET del 4 agosto 2025; la negoziazione su Nasdaq inizierà quella mattina con il prezzo aggiustato in base allo split, mantenendo lo stesso ticker ma con un nuovo CUSIP G0544E303.

Lo split ridurrà le azioni in circolazione da 9.142.869 a circa 1.828.574. Ogni cinque azioni pre-split saranno convertite in una azione post-split. Le frazioni di azioni saranno arrotondate per eccesso al numero intero più vicino, senza pagamento in contanti. Tutte le opzioni, warrant e altri titoli convertibili saranno adeguati proporzionalmente (numero azioni ÷ 5) secondo i termini del piano, arrotondati al numero intero più vicino.

Non sono state fornite altre informazioni operative o finanziarie; il documento riguarda esclusivamente le modalità e i tempi dell'azione societaria.

NewGenIvf Group Limited (Nasdaq: NIVF) ha declarado una división inversa de acciones de tipo 1 por 5 de sus Acciones Ordinarias Clase A. La acción será efectiva a las 12:01 a.m. ET el 4 de agosto de 2025; la negociación en Nasdaq comenzará esa mañana con el precio ajustado por la división bajo el mismo símbolo, pero con un nuevo CUSIP G0544E303.

La división reducirá las acciones en circulación de 9,142,869 a aproximadamente 1,828,574. Cada cinco acciones previas a la división se convertirán en una acción posterior a la división. Los derechos fraccionarios se redondearán hacia arriba al número entero más cercano, sin pago en efectivo. Todas las opciones, warrants y otros valores convertibles se ajustarán proporcionalmente (cantidad de acciones ÷ 5) según los términos del plan, redondeados a acciones enteras.

No se proporcionó otra información operativa o financiera; la presentación cubre estrictamente la mecánica y el calendario de la acción corporativa.

NewGenIvf Group Limited (Nasdaq: NIVF)는 클래스 A 보통주의 1대 5 역병합을 선언했습니다. 이 조치는 2025년 8월 4일 오전 12시 1분(동부시간)부터 효력이 발생하며, 나스닥에서 같은 티커로 새로운 CUSIP G0544E303와 함께 병합 조정된 가격으로 거래가 시작됩니다.

이번 역병합으로 유통 주식 수는 9,142,869주에서 약 1,828,574주로 줄어듭니다. 병합 전 다섯 주가 병합 후 한 주로 전환됩니다. 소수점 이하 주식은 현금 지급 없이 가장 가까운 정수 주식으로 올림 처리됩니다. 모든 옵션, 워런트 및 기타 전환 증권은 계획 조건에 따라 비례 조정(주식 수 ÷ 5)되며, 정수 주식으로 반올림됩니다.

기타 운영 또는 재무 정보는 제공되지 않았으며, 제출 서류는 이번 기업 행위의 절차와 일정에 관한 내용만 포함하고 있습니다.

NewGenIvf Group Limited (Nasdaq : NIVF) a annoncé un regroupement d’actions inversé de type 1 pour 5 de ses actions ordinaires de classe A. Cette opération prendra effet à 00h01 ET le 4 août 2025 ; les transactions sur le Nasdaq commenceront ce matin-là avec un cours ajusté suite au regroupement, sous le même symbole, mais avec un nouveau CUSIP G0544E303.

Le regroupement réduira le nombre d’actions en circulation de 9 142 869 à environ 1 828 574. Chaque groupe de cinq actions avant regroupement sera converti en une action après regroupement. Les fractions d’actions seront arrondies à l’action entière la plus proche, sans paiement en espèces. Toutes les options, bons de souscription et autres titres convertibles seront ajustés proportionnellement (nombre d’actions ÷ 5) conformément aux termes du plan, arrondis à l’action entière la plus proche.

Aucune autre information opérationnelle ou financière n’a été fournie ; le dépôt concerne strictement les modalités et le calendrier de cette opération corporative.

NewGenIvf Group Limited (Nasdaq: NIVF) hat eine 1-zu-5 Reverse-Aktienzusammenlegung seiner Stammaktien der Klasse A angekündigt. Die Maßnahme wird am 4. August 2025 um 0:01 Uhr ET wirksam; der Handel an der Nasdaq beginnt an diesem Morgen mit dem an die Zusammenlegung angepassten Kurs unter dem gleichen Ticker, jedoch mit neuer CUSIP G0544E303.

Die Zusammenlegung reduziert die ausstehenden Aktien von 9.142.869 auf ca. 1.828.574. Je fünf Aktien vor der Zusammenlegung werden zu einer Aktie nach der Zusammenlegung. Bruchteile werden auf die nächste ganze Aktie aufgerundet – es erfolgt keine Barauszahlung. Alle Optionen, Warrants und sonstigen wandelbaren Wertpapiere werden proportional (Anzahl Aktien ÷ 5) gemäß den Planbedingungen angepasst und auf ganze Aktien gerundet.

Weitere operative oder finanzielle Informationen wurden nicht bereitgestellt; die Einreichung betrifft ausschließlich die Mechanik und den Zeitplan der Unternehmensmaßnahme.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: 1-for-5 reverse split is structurally neutral; improves per-share price, unchanged market cap.

The filing contains no earnings or guidance, only the corporate action. Reverse splits are accounting events that multiply share price while reducing share count, leaving market capitalization intact. NIVF avoids fractional shares by rounding up, slightly increasing share total versus pure division, but the effect is immaterial. Option and warrant contracts are automatically adjusted, preventing unintended dilution. Without context on why the split is undertaken (e.g., listing compliance), impact is best viewed as neutral for valuation, though liquidity per share may decline as float shrinks. Investors should monitor post-split bid-ask spreads and any subsequent strategic announcements.

NewGenIvf Group Limited (Nasdaq: NIVF) ha annunciato uno frazionamento azionario inverso di tipo 1-per-5 delle sue Azioni Ordinarie di Classe A. L'operazione entrerà in vigore alle 12:01 a.m. ET del 4 agosto 2025; la negoziazione su Nasdaq inizierà quella mattina con il prezzo aggiustato in base allo split, mantenendo lo stesso ticker ma con un nuovo CUSIP G0544E303.

Lo split ridurrà le azioni in circolazione da 9.142.869 a circa 1.828.574. Ogni cinque azioni pre-split saranno convertite in una azione post-split. Le frazioni di azioni saranno arrotondate per eccesso al numero intero più vicino, senza pagamento in contanti. Tutte le opzioni, warrant e altri titoli convertibili saranno adeguati proporzionalmente (numero azioni ÷ 5) secondo i termini del piano, arrotondati al numero intero più vicino.

Non sono state fornite altre informazioni operative o finanziarie; il documento riguarda esclusivamente le modalità e i tempi dell'azione societaria.

NewGenIvf Group Limited (Nasdaq: NIVF) ha declarado una división inversa de acciones de tipo 1 por 5 de sus Acciones Ordinarias Clase A. La acción será efectiva a las 12:01 a.m. ET el 4 de agosto de 2025; la negociación en Nasdaq comenzará esa mañana con el precio ajustado por la división bajo el mismo símbolo, pero con un nuevo CUSIP G0544E303.

La división reducirá las acciones en circulación de 9,142,869 a aproximadamente 1,828,574. Cada cinco acciones previas a la división se convertirán en una acción posterior a la división. Los derechos fraccionarios se redondearán hacia arriba al número entero más cercano, sin pago en efectivo. Todas las opciones, warrants y otros valores convertibles se ajustarán proporcionalmente (cantidad de acciones ÷ 5) según los términos del plan, redondeados a acciones enteras.

No se proporcionó otra información operativa o financiera; la presentación cubre estrictamente la mecánica y el calendario de la acción corporativa.

NewGenIvf Group Limited (Nasdaq: NIVF)는 클래스 A 보통주의 1대 5 역병합을 선언했습니다. 이 조치는 2025년 8월 4일 오전 12시 1분(동부시간)부터 효력이 발생하며, 나스닥에서 같은 티커로 새로운 CUSIP G0544E303와 함께 병합 조정된 가격으로 거래가 시작됩니다.

이번 역병합으로 유통 주식 수는 9,142,869주에서 약 1,828,574주로 줄어듭니다. 병합 전 다섯 주가 병합 후 한 주로 전환됩니다. 소수점 이하 주식은 현금 지급 없이 가장 가까운 정수 주식으로 올림 처리됩니다. 모든 옵션, 워런트 및 기타 전환 증권은 계획 조건에 따라 비례 조정(주식 수 ÷ 5)되며, 정수 주식으로 반올림됩니다.

기타 운영 또는 재무 정보는 제공되지 않았으며, 제출 서류는 이번 기업 행위의 절차와 일정에 관한 내용만 포함하고 있습니다.

NewGenIvf Group Limited (Nasdaq : NIVF) a annoncé un regroupement d’actions inversé de type 1 pour 5 de ses actions ordinaires de classe A. Cette opération prendra effet à 00h01 ET le 4 août 2025 ; les transactions sur le Nasdaq commenceront ce matin-là avec un cours ajusté suite au regroupement, sous le même symbole, mais avec un nouveau CUSIP G0544E303.

Le regroupement réduira le nombre d’actions en circulation de 9 142 869 à environ 1 828 574. Chaque groupe de cinq actions avant regroupement sera converti en une action après regroupement. Les fractions d’actions seront arrondies à l’action entière la plus proche, sans paiement en espèces. Toutes les options, bons de souscription et autres titres convertibles seront ajustés proportionnellement (nombre d’actions ÷ 5) conformément aux termes du plan, arrondis à l’action entière la plus proche.

Aucune autre information opérationnelle ou financière n’a été fournie ; le dépôt concerne strictement les modalités et le calendrier de cette opération corporative.

NewGenIvf Group Limited (Nasdaq: NIVF) hat eine 1-zu-5 Reverse-Aktienzusammenlegung seiner Stammaktien der Klasse A angekündigt. Die Maßnahme wird am 4. August 2025 um 0:01 Uhr ET wirksam; der Handel an der Nasdaq beginnt an diesem Morgen mit dem an die Zusammenlegung angepassten Kurs unter dem gleichen Ticker, jedoch mit neuer CUSIP G0544E303.

Die Zusammenlegung reduziert die ausstehenden Aktien von 9.142.869 auf ca. 1.828.574. Je fünf Aktien vor der Zusammenlegung werden zu einer Aktie nach der Zusammenlegung. Bruchteile werden auf die nächste ganze Aktie aufgerundet – es erfolgt keine Barauszahlung. Alle Optionen, Warrants und sonstigen wandelbaren Wertpapiere werden proportional (Anzahl Aktien ÷ 5) gemäß den Planbedingungen angepasst und auf ganze Aktien gerundet.

Weitere operative oder finanzielle Informationen wurden nicht bereitgestellt; die Einreichung betrifft ausschließlich die Mechanik und den Zeitplan der Unternehmensmaßnahme.

 

 

As filed with the Securities and Exchange Commission on July 28, 2025

 

  Registration No. 333-238749
  Registration No. 333-238748
  Registration No. 333-205722
  Registration No. 333-134585
  Registration No. 333-58682  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 1
TO

 

FORM S-8 REGISTRATION STATEMENT NO. 333-238749
FORM S-8 REGISTRATION STATEMENT NO. 333-238748
FORM S-8 REGISTRATION STATEMENT NO. 333-205722
FORM S-8 REGISTRATION STATEMENT NO. 333-134585
FORM S-8 REGISTRATION STATEMENT NO. 333-58682

 

UNDER THE SECURITIES ACT OF 1933

 

PENNS WOODS BANCORP, INC.

(Exact name of registrant as specified in its charter)

 

Pennsylvania    23-2226454
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

 

300 Market Street, P.O. Box 967
Williamsport, Pennsylvania 17703-0967

(Address, including zip code, of registrant’s principal executive offices)

 

Penns Woods Bancorp, Inc. 2020 Non-Employee Director Compensation Plan
Penns Woods Bancorp, Inc. 2020 Equity Incentive Plan
Penns Woods Bancorp, Inc. 2014 Equity Incentive Plan
Penns Woods Bancorp, Inc. 2006 Employee Stock Purchase Plan
Penns Woods Bancorp, Inc. 1998 Stock Option Plan
(Full titles of the plans)

 

Douglas M. Schosser 
Chief Financial Officer 
Northwest Bancshares, Inc.
as successor by merger to Penns Woods Bancorp, Inc. 
3 Easton Oval Street, Suite 500 
Columbus, Ohio 43219
(814) 726-2140

(Name, address, and telephone number, including area code, of agent for service)

 

Copies to:

Michael Dailey, Esq.
Dinsmore & Shohl LLP 
191 W. Nationwide Blvd., Suite 200
Columbus, Ohio 43215 
(614) 628-6921

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨   Accelerated filer ¨
Non-accelerated filer x   Smaller reporting company x
Emerging growth company ¨      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

 

 

 

 

 

 

DEREGISTRATION OF SECURITIES

 

Penns Woods Bancorp, Inc., a Pennsylvania corporation (the “Registrant”), is filing with the U.S. Securities and Exchange Commission these post-effective amendments (the “Post-Effective Amendments”) to terminate all offerings under the following Registration Statements on Form S-8 (the “Registration Statements”) and to withdraw and deregister all shares of common stock, $5.55 par value per share, of the Registrant (the “Shares”) previously registered under the Registration Statements, together with any and all plan interests and other securities registered thereunder:

 

Registration Statement No. 333-238749, filed on May 28, 2020, relating to the registration of 100,000 Shares issuable under the Penns Woods Bancorp, Inc. 2020 Non-Employee Director Compensation Plan;
Registration Statement No. 333-238748, filed on May 28, 2020, relating to the registration of 750,000 Shares issuable under the Penns Woods Bancorp, Inc. 2020 Equity Incentive Plan;
Registration Statement No. 333-205722, filed on July 17, 2015, relating to the registration of 602,500 Shares issuable under the Penns Woods Bancorp, Inc. 2014 Equity Incentive Plan;
Registration Statement No. 333-134585, filed on May 31, 2006, relating to the registration of 1,000,000 Shares issuable under the Penns Woods Bancorp, Inc. 2006 Employee Stock Purchase Plan; and
Registration Statement No. 333-58682, filed on April 11, 2001, relating to the registration of 100,000 Shares issuable under the Penns Woods Bancorp, Inc. 1998 Stock Option Plan.

 

On July 25, 2025, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 16, 2024, by and between the Registrant and Northwest Bancshares, a Maryland corporation (“Northwest”), the Registrant merged with and into Northwest (the “Merger”), with Northwest being the surviving corporation of the Merger.

 

As a result of the Merger, the Registrant has terminated any and all offerings of the Registrant’s securities pursuant to the Registration Statements. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any securities that had been registered under the Registration Statements which remain unsold at the termination of the offerings, the Registrant hereby removes from registration by means of these Post-Effective Amendments all such securities registered under the Registration Statements that remain unsold as of the date hereof. Each Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities, and the Registrant hereby terminates the effectiveness of the Registration Statements.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements described above to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Columbus, State of Ohio, on this 28th day of July, 2025.

 

  NORTHWEST BANCSHARES, INC.
as successor by merger to PENNS WOODS BANCORP, INC.
   
  By: /s/Douglas M. Schosser
  Name: Douglas M. Schosser
  Title: Chief Financial Officer

 

Pursuant to the Rule 478 of the Securities Act of 1933, as amended, no other person is required to sign the Post-Effective Amendment.

 

 

 

Penns Woods Bancorp Inc

NASDAQ:PWOD

PWOD Rankings

PWOD Latest News

PWOD Latest SEC Filings

PWOD Stock Data

228.43M
7.23M
4.75%
29.54%
0.44%
Banks - Regional
State Commercial Banks
Link
United States
JERSEY SHORE